Kick off 2026 and set the tone for the year at 18th Annual
Pre-Filled Syringes and Injectable Drug Devices Conference!
Join us in London next January where we will unite leaders and innovators from the device development industry. This highly anticipated conference offers unparalleled opportunities to explore the latest advances in combination product technology, share insights, and foster collaboration across a dynamic three-day program.
As part of the leading Injectable Drug Delivery Series, the event features:
- Pre-Conference Focus Day: PFS Design for Enhanced Drug Delivery
- Two-Day Main Conference: Morning keynote plenaries and afternoon parallel topic streams addressing the industry’s most pressing challenges, including:
- Large-Volume Drug Delivery Solutions
- Sustainability in Medical Devices
- Advancements in Primary Drug Container Development and Biocompatibility
- Digital Health Technologies and Connected Devices
This conference not only provides actionable insights to elevate your injectable device portfolio but also offers invaluable networking opportunities with key players across the industry.
Mark your calendar and be part of this must-attend event in January 2026. We look forward to welcoming you to London!
2026 Speakers
- Abby Lambretti, Senior Scientist II, AbbVie
- Alex Fong, Research and Insights Manager, Owen Mumford Ltd
- Alison Skelley, Chief Science Officer, Zeon Specialty Material Inc.
- Andreas Emmendoerffer, Principal Regulatory Program Director, Roche
- Andrew Chapman, Senior Director, AstraZeneca
- Anja Hartmann, Lead Auditor / Product Specialist, TUV SUD Product Service GmbH
- Berengere Paris, Regulatory Affairs Specialist, RA Devices, Novo Nordisk
- Berna Kosekaya, Regulatory Professional, RA CMC & Devices/RA Device, Novo Nordisk
- Cedric Gysel, Chief Changemaker, Be Circular
- Charles Potter, Project and Technical Leader, Chiesi Ltd
- Charlie Dean, Head of Sustainable Medical Technology, Cambridge Consultants Ltd
- Chris Smith, Director, Teva Pharmaceuticals
- Conor O'Neill, Head of Packaging Development and Design, GSK
- Courtney Soulsby, Global Director, Healthcare and Life Sciences, BSI
- David Harrison, Business Lead, Drug Products and Devices, UCB
- Duncan Ritchie, Associate Principal Device Engineer, AstraZeneca
- Farshad Ramazani, Formulation Project Leader Senior Expert Science and Technology, Novartis Pharma AG
- Fatima Bennai-Sanfourche, Global Senior Director for QA & RA Compliance, Medical Devices, Combination Products & eHealth, Bayer
- George Moore-Arthur, Senior Global Regulatory Professional, Novo Nordisk
- Senior Representative, Gerresheimer
- Senior Representative, Haselmeier GmbH
- Hollie Gladwin, Technical Scientist, Physical and Combination Devices, Cormica
- Jacob Moberg Sandager, Senior Circular Plastic Engineer, Novo Nordisk
- Javad Jabbari, Director Regulatory Affairs RA Device and Combination Products, Ascendis Pharma
- John Merhige, CEO, Credence MedSystems, Inc.
- Juan Martin Carriquiry, Director RA Medical Devices & Combination Products, Novartis
- Jussi Haikarainen, Director, Device Development, AbbVie
- Kristine Berkenhoff, Head of Laboratory, Boehringer Ingelheim Pharma GmbH & Co. KG
- Louise Place, Director, Devices, Global CMC Regulatory Affairs, GSK
- Marc Egen, Head of Primary Packaging & Process Development, Boehringer Ingelheim Pharma Gmbh & Co. KG
- Mario Hirth, Director Global Verification Testing, AbbVie
- Matt Nicolas, Device Engineering Associate Director, GSK
- Max Dixon, Lead Applied Sciences Engineer, Crux Product Design
- Senior Representative, MGS Mfg. Group, Inc
- Senior Representative, Nemer
- Paul Draper, Senior Sector Manager Medical and Scientific, DCA
- Philip Canner, Head of Drug Delivery, Cambridge Consultants
- Rachel Koppelman, Head of Device Engineering, Sandoz
- Richard Crowther, Sr Manager Regulatory Affairs, Amgen
- Richard Kieran, Director of Business Development, West Pharmaceutical Services
- Richard Wedge, Associate Research Fellow, Pfizer
- Rob Veasey, Senior Sector Manager Medical & Scientific, DCA
- Sandra Einemann, Customer Relationship Manager, TUV SUD Product Service GmbH
- Simon Wilson, Device Development Lead, Pfizer
- Soren Skov, Senior Human Factors Engineer, Roche
- Steve Hoare, Deputy Director, Partnerships, Medicines and Healthcare products Regulatory Agency (MHRA)
- Tarja Nurmi, Senior Expert, Extractables & Leachables, Bayer
- Theresa Jeary, Global Head, Medicinal & Biologics Team, BSI
- Thomas Wejs Moller, Senior RA Policy Director, Novo Nordisk
- Tiffany McIntire, Device Team Leader, Roche
- Tony Haythornthwaite, Associate Director Device Engineering, GSK
- Senior Representative, West Pharmaceutical Services
- Xavier Donnette, Device Program Lead, UCB
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Royal Garden Hotel
2 - 24 Kensington High Street, W8 4PT
London, United Kingdom
